MANAGEMENT OF A PATIENT WITH SEVERE COURSE OF PSORIATIC ARTHRITIS

QR Code

MANAGEMENT OF A PATIENT WITH SEVERE COURSE OF PSORIATIC ARTHRITIS

A history case of a patient with psoriatic arthritis, characterized by severe disease course, systemic symptoms, significantly increased laboratory markers, polyarticular syndrome, typical skin and nails changes, rapid development of patient’s disability and low quality of his and his family life is...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. I. Alexeeva, T. M. Bzarova, A. N. Fetisova, S. I. Valieva, T. V. Sleptsova, K. B. Isaeva, R. V. Denisova, E. V. Mitenko, E.G. Chistyakova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2013-05-01
Series:	Вопросы современной педиатрии
Subjects:	children, psoriatic arthritis, psoriasis, adalimumab, etanercept
Online Access:	https://vsp.spr-journal.ru/jour/article/view/336
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01)

Current views on the pharmacotherapy of psoriatic arthritis
by: G. G. Taradin, et al.
Published: (2016-01-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: S. V. Smirnova, et al.
Published: (2014-08-01)

AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
by: A. A. Barilo, et al.
Published: (2019-01-01)

Can the development of psoriatic arthritis be prevented in patients with psoriasis?
by: E. L. Nasonov, et al.
Published: (2019-07-01)

Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
by: V. V. Didenko, et al.
Published: (2021-05-01)

A case of vitiligo regression in a patient with psoriasis and psoriatic arthritis receiving adalimumab therapy
by: N. S. Rudneva, et al.
Published: (2021-12-01)

Psoriasis and psoriatic arthritis: Topical issues
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

Prevalence of psoriatic arthritis and comorbidities in patients with severe psoriasis: Data of a retrospective analysis of a hospital cohort
by: N. V. Batkaeva, et al.
Published: (2017-03-01)

PSORIATIC ARTHRITIS: CLASSIFICATION, CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT
by: T. V. Korotaeva
Published: (2014-12-01)

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-12-01)

Relationship between the prevalence of cardiometabolic diseases and the presence of psoriatic arthritis in Russian patients with psoriasis
by: E. V. Bogdanova, et al.
Published: (2023-04-01)

Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy
by: E. I. Markelova, et al.
Published: (2019-11-01)

Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01)

RETRACTED: The clinical features and course of psoriatic arthritis in children
by: S. N. Chebysheva, et al.
Published: (2014-06-01)

GENETIC FACTORS IN IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: M. V. Smolnikova, et al.
Published: (2014-08-01)

RESULTS OF USTEKINUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION ACCORDING TO THE DATA OF PSUMMIT 1 AND PSUMMIT 2
by: Yu. L. Korsakova, et al.
Published: (2015-04-01)

Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2015-09-01)

Use of phosphodiesterase 4 inhibitor in patients with psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2017-04-01)

Ixekizumab in the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-12-01)

Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016-01-01)

THE EFFECT OF AN ANTI-TUMOR NECROSIS FACTOR-? AGENT ON DISEASE ACTIVITY,BLOOD RHEOLOGICAL PROPERTIES, AND THE ARTERIAL WALL IN PSORIATIC ARTHRITIS
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2010-06-01)

The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2018-04-01)

EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: K. B. Isaeva, et al.
Published: (2014-07-01)

Pattern of Circulating Microrna's in Patients with Psoriatic Arthritis
by: P. A. Shesternya, et al.
Published: (2024-03-01)

Registers of psoriatic arthritis. Literature review
by: A. D. Koltakova
Published: (2019-05-01)

Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 1.
by: N. O. Pereverzina, et al.
Published: (2022-02-01)

Systematic review and meta-analysis: risk factors for psoriatic arthritis. Part 2
by: N. O. Pereverzina, et al.
Published: (2022-05-01)

Concurrence of systemic lupus erythematosus and psoriatic arthritis: literature data and a case report
by: E. M. Agafonova, et al.
Published: (2018-12-01)

LIVER DAMAGE IN PSORIASIS AND PSORIATIC ARTHRITIS: A LITERATURE REVIEW
by: Yu. L. Korsakova, et al.
Published: (2017-09-01)

PSORIATIC ARTHRITIS: CLASSIFICATION, CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT
by: T. V. Korotaev, et al.
Published: (2018-03-01)

LONG TERM FOLLOW-UP ON EFFECTIVENESS AND SAFETY OF ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS
by: A. A. Baranov, et al.
Published: (2015-04-01)

The efficacy of the interleukin 17 inhibitor ixekizumab in psoriatic arthritis: data from real clinical practice
by: I. M. Marusenko, et al.
Published: (2021-06-01)

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE
by: A. S. Kolbin, et al.
Published: (2016-12-01)

Plasma gelsolin and matrix metalloproteinase-3 levels as diagnostic markers for psoriatic arthritis
by: Y. A. Zamzam, et al.
Published: (2024-12-01)

EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α — ADALIMUMAB — IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

Immunogenicity induced by biologicals in the treatment of psoriasis and psoriatic arthritis: View of the problem
by: T. V. Korotaeva
Published: (2016-01-01)

Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice
by: M. N. Chamurlieva, et al.
Published: (2019-10-01)